US Patent Issued to Shanghai Runshi Medical Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences on April 21 for "Use of CSF-1R kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,375, issued on April 21, was assigned to Shanghai Runshi Medical Technology Co. Ltd (Shanghai) and Shanghai Institute of Materia Medica, Chinese Academy of Sciences (Shanghai).

"Use of CSF-1R kinase inhibitor" was invented by Ao Zhang (Shanghai), Meiyu Geng (Shanghai), Jing Ai (Shanghai), Caixia Wang (Shanghai), Xia Peng (Shanghai), Yang Zhang (Shanghai) and Jian Ding (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of a compound of general formula (A) which is a CFS-IR kinase inhibitor or a pharmaceutically acceptable salt thereof in the preparation of medicaments for treating diseases related to CSF-1R kinase signal transduction pathw...